Loading company…
Beijing-based Sihuan Pharmaceutical handles R&D, production and sales of drugs across several therapeutic areas.
Based in Beijing, China, and founded in 2001, Sihuan Pharmaceutical Holdings Group Ltd integrates research, production and sales. It was listed in Singapore in March 2007, privatized and delisted in 2009, and listed on the Hong Kong main board in 2010 under stock code 00460. Product lines cover cardio-cerebral vascular, digestive, anti-infective, metabolism, respiratory and neurology. In 2021 its operating profit was CNY 486.049 million and net profit was CNY 232.77 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in